NeuroKai

NeuroKai appears to be a small active company focused on neurotechnology solutions, mainly for health, wellness, and biometrics-related applications rather than therapeutic drug development. Publicly available evidence suggests it operates in EEG and ECG biometrics and broader neurotechnology services, but detailed primary-source corporate information is limited. I did not find evidence that NeuroKai is a biotech, pharma, CRO, or therapeutics developer with a disclosed drug pipeline. Instead, the company is better characterized as a health-tech or neurotechnology business with commercial or service-oriented activity. Because source quality is limited and much of the available information comes from market-report aggregators rather than robust company disclosures, several fields below are left null or conservative.